Skip to main content

ADVERTISEMENT

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Pharma Insights
04/20/2022
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Marissa Baker-Wagner, MPH
Ronaé McLin, MPH
Dr Okeyan and colleagues discuss key areas where big data analytics are being leveraged in health care, the implications to payer and pharma stakeholders, and key considerations for success.
Dr Okeyan and colleagues discuss key areas where big data analytics are being leveraged in health care, the implications to payer and pharma stakeholders, and key considerations for success.
Dr Okeyan and colleagues ...
04/20/2022
Journal of Clinical Pathways
Pharma Insights
03/16/2022
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Cynthia Miller, MD, MPH
Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues propose a vision for the future of the patient/consumer experience to serve as a blueprint for organizations to develop and implement a strategy that is both effective and in alignment...
Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues propose a vision for the future of the patient/consumer experience to serve as a blueprint for organizations to develop and implement a strategy that is both effective and in alignment...
Elizabeth Oyekan, PharmD, FCSHP,...
03/16/2022
Journal of Clinical Pathways
Pharma Insights
09/23/2021
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Dominic Galante, MD
Elizabeth Oyekan, PharmD, and Dominic Galante, MD, discuss next generation access decision makers and value-based care in the midst of the pandemic and beyond.
Elizabeth Oyekan, PharmD, and Dominic Galante, MD, discuss next generation access decision makers and value-based care in the midst of the pandemic and beyond.
Elizabeth Oyekan, PharmD, and...
09/23/2021
Journal of Clinical Pathways
Pharma Insights
06/21/2021
Maureen Hennessey, PhD, CPCC, CPHQ
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...
Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...
Maureen Hennessey, PhD, CPCC,...
06/21/2021
Journal of Clinical Pathways
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
Pharma Insights
03/16/2020
Avi Mamidi, PharmD
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Jeremy Schafer, PharmD, MBA
Larry Blandford, PharmD—Column Editor
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The...
03/16/2020
Journal of Clinical Pathways